COWZ: Health Care's Potential Turnaround Is Bullish (Rating Upgrade)

The Health Care Select Sector SPDR Fund (XLV) significantly outperformed last week, gaining 4.7% and marking its best weekly performance since October 2022. This sector rebound aligns with an analyst's upgrade of COWZ from 'hold' to 'buy', citing improved risk/reward and modest valuations within the healthcare sector, which now constitutes COWZ's largest weighting. The upgrade anticipates future outperformance for healthcare, driven by its cheap valuation and strengthening technicals, despite potential seasonal weakness through October.

Analysis

The healthcare sector demonstrated significant strength, with the Health Care Select Sector SPDR Fund (XLV) posting a 4.7% gain last week, its strongest weekly performance since October 2022. This rebound serves as a key catalyst for an analyst's upgrade of the Pacer US Cash Cows 100 ETF (COWZ) from 'hold' to 'buy'. The bullish thesis for COWZ is anchored in its now-largest sector weighting in healthcare, coupled with the sector's attractive valuation and improving technical indicators following a period of underperformance relative to the S&P 500. Specifically, COWZ is highlighted for its value characteristics, trading at a price-to-earnings ratio of just 13.6x with a low PEG ratio. However, the analysis is not without caution, identifying share momentum and historical volatility as remaining concerns. Furthermore, a potential seasonal headwind through October is noted as a risk, though the overall outlook remains positive, supported by technicals and the prospect of continued sector rotation into undervalued areas like healthcare.

Key Decisions for Investors

• Investors could consider increasing allocation to the healthcare sector, given its recent momentum and the argument for its relatively cheap valuation and strengthening technicals.
• For those seeking value-oriented exposure, COWZ offers a specific vehicle to play a healthcare rebound, trading at an attractive 13.6x earnings multiple following a period of underperformance.
• Despite the bullish upgrade, it is prudent to monitor the noted risks, including seasonal weakness through October and the fund's historical volatility, which may influence position sizing and timing.